Table 1

Patient characteristics distribution of the metastatic and non-metastatic PTMC
Patient characteristics Metastatic (n = 8) Non-metastatic (n = 28) P-value
Gender
 Female 4 (50%) 23 (82.1%) 0.086
 Male 4 (50%) 5 (17.9%)
Histological subtype
 Classical 5 (62.5%) 11 (39.3%) 0.742
 Follicular 3 (37.5%) 14 (50%)
 Oncocytic 0 (0) 2 (7.1%)
 Diffuse sclerosing 0 (0) 1 (3.6%)
Multifocal 6 (75%) 16 (57.1%) 0.441
Lymph node metastasis at diagnosis 8 (100%) 0 <0.001
Extrathyroidal extension 2 (25%) 3 (10.7%) 0.305
Angioinvasion 3 (37.5%) 2 (7.1%) 0.061
TNM stage
 I&II 4 (50%) 26 (92.9%) 0.03
 III&IV 4 (50%) 2 (7.1%)
I-131 No.
 0 1 (12.5%) 24 (85.7%) <0.001
 ≥ 1 7 (87.5%) 4 (14.3%)

Kunavisarut et al.

Kunavisarut et al. BMC Cancer 2012 12:523   doi:10.1186/1471-2407-12-523

Open Data